Preventing drug interactions in the home: a five-step approach for client teaching.

C. O. Long, Robert Ismeurt, P. A. White

Research output: Contribution to journalReview article

Abstract

An important area of pharmacologic concern, particularly in the home setting, is that of drug interactions. The 1997 action by the Food and Drug Administration (FDA) to remove fenfluramine and dexfenfluramine, causing the weight-control phen-fen scare, is a high-profile example of an issue that occurs every day with little fanfare. In drug administration and supervision, there are many factors of concern. This article illustrates five basic factors to consider to prevent drug interactions in the home setting.

Original languageEnglish (US)
Pages (from-to)106-112
Number of pages7
JournalHome Healthcare Nurse
Volume17
Issue number2
DOIs
StatePublished - Jan 1 1999

Fingerprint

Drug Interactions
Teaching
Dexfenfluramine
drug
Fenfluramine
United States Food and Drug Administration
interaction
Weights and Measures
supervision
Pharmaceutical Preparations

ASJC Scopus subject areas

  • Health(social science)
  • Community and Home Care
  • Advanced and Specialized Nursing

Cite this

Preventing drug interactions in the home : a five-step approach for client teaching. / Long, C. O.; Ismeurt, Robert; White, P. A.

In: Home Healthcare Nurse, Vol. 17, No. 2, 01.01.1999, p. 106-112.

Research output: Contribution to journalReview article

Long, C. O. ; Ismeurt, Robert ; White, P. A. / Preventing drug interactions in the home : a five-step approach for client teaching. In: Home Healthcare Nurse. 1999 ; Vol. 17, No. 2. pp. 106-112.
@article{56d1f19e8e5c4082a46e78593800da76,
title = "Preventing drug interactions in the home: a five-step approach for client teaching.",
abstract = "An important area of pharmacologic concern, particularly in the home setting, is that of drug interactions. The 1997 action by the Food and Drug Administration (FDA) to remove fenfluramine and dexfenfluramine, causing the weight-control phen-fen scare, is a high-profile example of an issue that occurs every day with little fanfare. In drug administration and supervision, there are many factors of concern. This article illustrates five basic factors to consider to prevent drug interactions in the home setting.",
author = "Long, {C. O.} and Robert Ismeurt and White, {P. A.}",
year = "1999",
month = "1",
day = "1",
doi = "10.1097/00004045-199902000-00010",
language = "English (US)",
volume = "17",
pages = "106--112",
journal = "Home healthcare now",
issn = "2374-4529",
publisher = "Lippincott Williams and Wilkins",
number = "2",

}

TY - JOUR

T1 - Preventing drug interactions in the home

T2 - a five-step approach for client teaching.

AU - Long, C. O.

AU - Ismeurt, Robert

AU - White, P. A.

PY - 1999/1/1

Y1 - 1999/1/1

N2 - An important area of pharmacologic concern, particularly in the home setting, is that of drug interactions. The 1997 action by the Food and Drug Administration (FDA) to remove fenfluramine and dexfenfluramine, causing the weight-control phen-fen scare, is a high-profile example of an issue that occurs every day with little fanfare. In drug administration and supervision, there are many factors of concern. This article illustrates five basic factors to consider to prevent drug interactions in the home setting.

AB - An important area of pharmacologic concern, particularly in the home setting, is that of drug interactions. The 1997 action by the Food and Drug Administration (FDA) to remove fenfluramine and dexfenfluramine, causing the weight-control phen-fen scare, is a high-profile example of an issue that occurs every day with little fanfare. In drug administration and supervision, there are many factors of concern. This article illustrates five basic factors to consider to prevent drug interactions in the home setting.

UR - http://www.scopus.com/inward/record.url?scp=0033069850&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033069850&partnerID=8YFLogxK

U2 - 10.1097/00004045-199902000-00010

DO - 10.1097/00004045-199902000-00010

M3 - Review article

C2 - 10358501

AN - SCOPUS:0033069850

VL - 17

SP - 106

EP - 112

JO - Home healthcare now

JF - Home healthcare now

SN - 2374-4529

IS - 2

ER -